Rappler
[OPINION] From Dengvaxia to Daraxonrasib: Can the Philippines restore trust in medical innovation?
By Jaemin Park
Findings about a novel targeted therapy for pancreatic cancer represent genuine hope. However, it may take time for Filipinos to trust it after its trauma from the Dengvaxia controversy.